跳至主要内容
临床试验/NCT01685944
NCT01685944已完成不适用

A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Effect of Pediococcus Pentosaceus LP28 on Obesity

Hiroshima University2 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
62
试验地点
2
主要终点
BMI

研究概览

简要总结

This study is designed to evaluate efficacy of Pediococcus pentosaceus LP28 in reducing body fat and body weight in subjects with BMI 25-30 kg/m2.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI 25-30 kg/m2

排除标准

  • Taking medicines or functional food that may affect body weight or body fat
  • Pregnant or nursing a child
  • Participation in any clinical trial within 90 days of the commencement of the trial
  • Renal or hepatic dysfunction
  • Heart disease

结局指标

主要结局

BMI

时间窗: Every day (Overall 14 weeks)

Body weight will be measured every morning.

Body fat

时间窗: Every 4 weeks (Overall 12 weeks)

次要结局

  • Fasting blood glucose(Every 4 weeks (Overall 12 weeks))
  • Leptin(Weeks 0 and 12)
  • Fasting insulin(Weeks 0 and 12)
  • Adiponectin(Weeks 0 and 12)
  • Resistin(Weeks 0 and 12)
  • Abdominal circumference(Every 4 weeks (Overall 12 weeks))
  • Serum triglyceride(Every 4 weeks (Overall 12 weeks))
  • Total cholesterol(Every 4 weeks (Overall 12 weeks))
  • HDL cholesterol(Every 4 weeks (Overall 12 weeks))
  • HOMA-R(Weeks 0 and 12)
  • LDL cholesterol(Every 4 weeks (Overall 12 weeks))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fumiko Higashikawa

Associate Professor

Hiroshima University

研究点 (2)

Loading locations...

相似试验